Welsbach Technology Metals Acquisition (NASDAQ:EMAT – Get Free Report) posted its earnings results on Friday. The company reported ($0.02) earnings per share for the quarter, Zacks reports.
Welsbach Technology Metals Acquisition Stock Performance
Shares of Welsbach Technology Metals Acquisition stock traded down $0.30 during trading on Friday, reaching $8.02. The company had a trading volume of 55,234 shares, compared to its average volume of 171,142. The firm’s fifty day simple moving average is $8.15. Welsbach Technology Metals Acquisition has a fifty-two week low of $5.50 and a fifty-two week high of $24.08.
Analyst Ratings Changes
EMAT has been the subject of a number of analyst reports. Clear Str raised Welsbach Technology Metals Acquisition to a “strong-buy” rating in a report on Wednesday, February 18th. Wall Street Zen upgraded Welsbach Technology Metals Acquisition to a “sell” rating in a report on Saturday, March 14th. Finally, Weiss Ratings started coverage on shares of Welsbach Technology Metals Acquisition in a report on Tuesday, January 27th. They set a “sell (d-)” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, Welsbach Technology Metals Acquisition currently has a consensus rating of “Moderate Buy”.
About Welsbach Technology Metals Acquisition
Welsbach Technology Metals Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on the technology metals and energy transition metals sectors. Welsbach Technology Metals Acquisition Corp. was incorporated in 2021 and is based in Lombard, Illinois.
Further Reading
- Five stocks we like better than Welsbach Technology Metals Acquisition
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
- Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half
- Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
Receive News & Ratings for Welsbach Technology Metals Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welsbach Technology Metals Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
